Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
QLGNCompany Name
QUALIGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQQUALIGEN THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
QLGN - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 2.98M | 0 | $ 0 |
| 3/31/2025 | $ 5.02M | 0 | $ 0 |
| 12/31/2024 | $ 5.58M | 0 | $ 0 |
| 9/30/2024 | $ 2.99M | 0 | $ 0 |
| 6/30/2024 | $ 2.47M | 0 | $ 0 |
| 3/31/2024 | $ 1.59M | 0.98 | $ 1.63M |
| 12/31/2023 | $ 2.41M | 0 | $ 0 |
| 9/30/2023 | $ 3.81M | 0.82 | $ 4.62M |
| 6/30/2023 | $ 5.31M | 0.87 | $ 6.07M |
| 3/31/2023 | $ 5.15M | 0.88 | $ 5.87M |
Key Performance Insights, Last 5 Years
- QUALIGEN THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 46.21.
- Over the past 5 years, QUALIGEN THERAPEUTICS INC's average P/S has been 7.39.
- The median P/S for QUALIGEN THERAPEUTICS INC during this period was 3.78
- QUALIGEN THERAPEUTICS INC reached its highest P/S over the past 5 years at 46.21.
- The lowest P/S recorded by QUALIGEN THERAPEUTICS INC in the same timeframe 0.82
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for QUALIGEN THERAPEUTICS INC is calculated as follows: Market Cap [ $ 80.48M ] / Revenues [ $ 1.74M ]
(=) P/S [ 46.21 ] QLGN - Price to Sales, Last 5 years
0.82
Minimum
Sep 30, 2023
46.21
Maximum
Sep 30, 2020
7.39
Average
3.78
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |